Autophagy is a highly regulated and multi-step biological process that serves to remove damaged cytoplasmic components and organelles. It has been suggested that the activation of autophagy may be a promising therapeutic strategy for
cancer treatment by triggering cell death. In this study, we reported that
cyclovirobuxine D (
CVB-D), an
alkaloid component in a traditional Chinese herb, could induce autophagy in the MCF-7 human
breast cancer cell line.
CVB-D inhibited the viability of MCF-7 cells in a concentration- and time-dependent manner. Activation of autophagy was characterized by transmission electron microscopy,
monodansylcadaverine staining, and expression of autophagy marker
microtubule-associated protein 1 light chain 3 (LC3). After
CVB-D treatment, a clear accumulation of autophagosomes was observed accompanied with elevated LC3 fluorescent puncta. Western blot analysis revealed that
CVB-D significantly promoted the conversion from LC3-I to LC3-II and the expression of
autophagy-related protein 5 (ATG5), which are both essential for autophagosome formation. On the other hand,
CVB-D-induced autophagy and decrease in cell viability could be blocked by
3-methyladenine, a well-established autophagy inhibitor. Moreover,
CVB-D attenuated the phosphorylation of Akt and mTOR, two pivotal suppressors in autophagy pathways. These findings shed new light on the pharmacological actions and mechanism of
CVB-D and may support the potential utility of autophagy inducers in
cancer treatment.